The man who had a blood clot filed a lawsuit against the Covid-19 vaccine manufacturer

The man who had a blood clot filed a lawsuit against the Covid-19 vaccine manufacturer


A 44-year-old man, who had a clot in his brain after receiving the Covid-19 vaccine and became unable to work due to a permanent illness, filed a lawsuit against the company that developed the mRNA type coronavirus vaccine.

The man who had a blood clot filed a lawsuit against the Covid-19 vaccine manufacturer

World social distance, which caused the death of millions of people worldwide, mask The coronavirus epidemic, which is being combated with mRNA-based vaccines developed and developed, continues to affect daily life with different variants.

The outcome of the lawsuit filed by the young couple is eagerly awaited.

But EnglandA man named Jamie Scott, who lives in , and received the mRNA-based Covid-19 vaccine developed by AstraZeneca, went to court due to the discomfort he experienced after receiving the vaccine.

Scott, 44, a father of two, said that he became ill and had a clot in his brain after receiving the Covid-19 vaccine in April 2021. Scott filed a lawsuit, explaining that he had a clot in his brain after the vaccine and that this caused permanent damage to his brain.

In the report of the British Daily Telegraph newspaper, it was stated that the possible risks of the vaccine were not adequately announced. Scott’s wife, Kate, said: “We have been trying to put pressure on the government for 18 months, but we have not been compensated for the inconvenience. “We also hold AstraZeneca responsible,” he said. The British media reported that the outcome of this case could turn into a lawsuit worth hundreds of millions of dollars and could set a precedent.

It will detect brain tumor... Simple and practical like the COVID testYou May Be Interested InIt will detect brain tumor… Simple and practical like the COVID testIs it right to underestimate Covid-19?You May Be Interested InIs it right to underestimate Covid-19?Pfizer made a loss in the third quarter as Covid-19 vaccine demand decreasedYou May Be Interested InPfizer made a loss in the third quarter as Covid-19 vaccine demand decreased





Source link